Ascendis Pharma A/S

ASND - Company ID 0001612042

Market cap$17.07 B

Rank#680

Filings754

Ascendis Pharma A/S has filed 754 public company documents between 2014 and 2026. The most frequent type is 6-k (411 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Continue researchASND overview$17.07 BMarket cap, financials, charts, and latest company context.

Continue researchMarket cap historyRank #680See the market value trend behind the filing history.

Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.

Continue researchCompare with LLYPeer viewPut ASND beside LLY across market cap, revenue, income, and filings.

Browse latest filings across all companies →Follow ASND via RSS

Similar companies to research next

LLYEli Lilly and Company

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Type	Filing	Filed	Period covered	Open
6-K	6-K	1y ago2024-12-30	2024-12-30	View filing
6-K	6-K	1y ago2024-12-17	2024-12-17	View filing
6-K	6-K	1y ago2024-12-12	2024-12-12	View filing
6-K	6-K	1y ago2024-12-11	2024-12-11	View filing
144	Insider sale notice	1y ago2024-12-10	-	View filing
144	Insider sale notice	1y ago2024-12-10	-	View filing
144	Insider sale notice	1y ago2024-12-10	-	View filing
144	Insider sale notice	1y ago2024-12-10	-	View filing
144	Insider sale notice	1y ago2024-12-10	-	View filing
144	Insider sale notice	1y ago2024-12-10	-	View filing
144	Insider sale notice	1y ago2024-12-10	-	View filing
144	Insider sale notice	1y ago2024-12-03	-	View filing
144	Insider sale notice	1y ago2024-11-19	-	View filing
SC 13G/A	Passive ownership stake (update)	1y ago2024-11-14	-	View filing
6-K	6-K	1y ago2024-11-14	2024-11-14	View filing
SC 13G/A	Passive ownership stake (update)	1y ago2024-11-14	-	View filing
6-K	6-K	1y ago2024-11-14	2024-09-30	View filing
SC 13G/A	Passive ownership stake (update)	1y ago2024-11-14	-	View filing
6-K	6-K	1y ago2024-11-13	2024-11-13	View filing
SC 13G/A	Passive ownership stake (update)	1y ago2024-11-12	-	View filing
SC 13G/A	Passive ownership stake (update)	1y ago2024-11-08	-	View filing
6-K	6-K	1y ago2024-11-04	2024-11-04	View filing
6-K	6-K	1y ago2024-10-09	2024-10-09	View filing
6-K	6-K	1y ago2024-09-30	2024-09-30	View filing
6-K	6-K	1y ago2024-09-27	2024-09-27	View filing
6-K	6-K	1y ago2024-09-23	2024-09-23	View filing
424B5	Prospectus supplement	1y ago2024-09-20	-	View filing
424B5	Prospectus supplement	1y ago2024-09-18	-	View filing
F-3ASR	F-3ASR	1y ago2024-09-18	-	View filing
6-K	6-K	1y ago2024-09-16	2024-09-16	View filing
6-K	6-K	1y ago2024-09-16	2024-09-16	View filing
6-K	6-K	1y ago2024-09-12	2024-09-11	View filing
6-K	6-K	1y ago2024-09-11	2024-09-11	View filing
S-8	Employee stock plan	1y ago2024-09-04	-	View filing
6-K	6-K	1y ago2024-09-03	2024-09-03	View filing
6-K	6-K	1y ago2024-09-03	2024-09-03	View filing
6-K	6-K	1y ago2024-09-03	2024-06-30	View filing
6-K	6-K	1y ago2024-08-14	2024-08-14	View filing
6-K	6-K	1y ago2024-08-12	2024-08-12	View filing
6-K	6-K	1y ago2024-07-10	2024-07-10	View filing
6-K	6-K	2y ago2024-06-28	2024-06-28	View filing
6-K	6-K	2y ago2024-06-12	2024-06-12	View filing
6-K	6-K	2y ago2024-05-31	2024-05-31	View filing
SD	SD	2y ago2024-05-29	-	View filing
6-K	6-K	2y ago2024-05-16	2024-05-16	View filing
6-K	6-K	2y ago2024-05-14	2024-05-14	View filing
6-K	6-K	2y ago2024-05-02	2024-05-02	View filing
6-K	6-K	2y ago2024-05-02	2024-05-02	View filing
6-K	6-K	2y ago2024-05-02	2024-03-31	View filing
6-K	6-K	2y ago2024-04-24	2024-04-24	View filing

Ascendis Pharma A/S

Similar companies to research next

Year